Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 27, 2015
Insider Transaction Report
Form 4
YORDON JEFFREY
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2015-02-25+9,945→ 686,014 total - Award
Stock Option to Buy
2015-02-25+18,468→ 18,468 totalExercise: $27.15Exp: 2025-02-25→ Common Stock (18,468 underlying)
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on February 25, 2016.